medigraphic.com
ISSN 1029-3035 (Digital)

2015, Número 2

<< Anterior

Mediciego 2015; 21 (2)


Guía Nacional de Consenso para el Diagnóstico y Tratamiento de las Emergencias Hiperglucémicas

Camacho AVJ, Caballero LA, Iglesias MI

Idioma: Español
Referencias bibliográficas: 93
Paginas: 140-197
Archivo PDF: 486.80 Kb.


RESUMEN

Introducción: las Guías de Consenso de mayor prestigio a nivel mundial no establecen recomendaciones específicas para el manejo del síndrome hiperglucémico (SHG) en el marco de los cuidados intensivos lo que estimula a las instituciones hospitalarias a desarrollar guías para el manejo, diagnóstico y tratamiento de este síndrome en cuidados intensivos adaptadas a los diferentes contextos regionales y/o nacionales. Objetivo: elaborar una guía de diagnóstico y tratamiento de las emergencias hiperglucémicas. Método: endocrinólogos e intensivistas en calidad de expertos, en representación de todo el país, se reunieron durante la Jornada por el 42 Aniversario de la Fundación del Centro de Atención al Diabético de La Habana, para la discusión preliminar de esta Guía Nacional. Resultados: luego de un amplio debate se estableció la versión preliminar de las guías, la cual detalla los criterios diagnósticos, objetivos, metas terapéuticas y tratamiento de los pacientes en SHG en su tránsito desde la admisión en la unidad de cuidados intensivos, hacia los cuidados intermedios y el alta hospitalaria. Se establecen las pautas de monitoreo, las insulinas aprobadas para su uso, las vías y esquemas terapéuticos en cada nivel de atención emergente, así como los criterios de transición terapéutica desde la infusión endovenosa continua de insulina hasta los esquemas de tratamiento intensivo basal-bolos indicados una vez compensado el paciente. Se establecen además las indicaciones para el manejo de los eventos hipoglucémicos y el manejo de la glucemia durante el periodo perioperatorio durante las intervenciones quirúrgicas electivas.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Chubb SP. Hyponatremia Treatment Guidelines 2007: Expert Panel Recommendations. Clin Biochem Rev. Feb 2009;30(1):35–8.

  2. American College of Endocrinology, American Diabetes Association. Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control. Endocr Pract. 2006;12:458-68.

  3. Adrogué HJ, Madias NE. The Challenge of Hyponatremia. J Am Soc Nephrol. 2012;23:1140–8.

  4. Adrogué HJ. Consequences of Inadequate Management of Hyponatremia. Am J Nephrol. 2005;25:240–9.

  5. American Diabetes Association. Medical Management of Type 1 Diabetes. 5th ed. Alexandria (VA): American Diabetes Association; 2008.

  6. American Diabetes Association. Management of Type 2 Diabetes. 6th ed. Alexandria (VA): American Diabetes Association; 2008.

  7. American Diabetes Association. Intensive Diabetes Management. 2nd ed. Alexandria (VA): American Diabetes Association; 1998.

  8. American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diab Care. 2011;34(1):S11-61.

  9. American Diabetes Association. Standards of Medical Care in Diabetes 2012. Diab Care. January 2012;35(1):S1-10.

  10. American Diabetes Association. Executive Summary: Standards of Medical Care in Diabetes- 2013. Diab Care 2013;36(1):S4-10.

  11. Avanzini F, Marelli G, Donzelli W, Busi G, Carbone S, Bellato L, et al. Transition From Intravenous to Subcutaneous Insulin Effectiveness and safety of a standardized protocol and predictors of outcome in patients with acute coronary syndrome. Diab Care. Jul 2011;34(7):1445–50.

  12. Bantle JP, Wylie-Rosett J, Albright AL. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diab Care. 2008;31(Suppl 1):S61–78.

  13. Bernard JB, Harper J, Muriello M, Rico E, Baldwin D. Treatment of inpatient hyperglycemia beginning in the emergency department: a randomized trial using insulins aspart and detemir compared with usual care. J Hosp Med. 2011;6:279–84.

  14. Bianchi C, Del Prato S. Metabolic Memory and Individual Treatment Aims in Type 2 Diabetes – Outcome-Lessons Learned from Large Clinical Trials. Rev Diabet Stud. 2011;8(3):432–40.

  15. Biswas M, Davies J S. Hyponatraemia in clinical practice. Postgrad Med J. 2007;83:373–8.

  16. Blackwell SC. Counterpoint: enough evidence to treat? The American College of Obstetricians and Gynecologists guidelines. Clin Chem. Jul 2012; 56(7):1098-100.

  17. Breithaupt T. Postoperative glycemic control in cardiac surgery patients. Proc (Bayl Univ Med Cent). 2010;23(1):79–82.

  18. Chaithongdi N, Koch CA, Geraci SA. Diagnosis and management of hyperglycemic emergencies. Hormones (Athens). 2011;10(4):250-60.

  19. Chappell LC, Germain SJ. Controversies in management of diabetes from preconception to the postnatal period. BMJ. 2008;336(7646):717–8.

  20. Chew EY, Ambrosius WT, Davis MD, ACCORD Study Group. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med. 2010;363:233–44.

  21. Cowie CC, Rust KF, Byrd-Holt DD. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diab Care. 2011;33:562–8.

  22. Cryer PE. Diverse causes of hypoglycemia associated autonomic failure in diabetes. N Engl J Med. 2004; 350:2272–9.

  23. Czosnowski QA, Lobo BL, Broyles JE, Deaton PR, Finch CK. Evaluation of glycemic control following discontinuation of an intensive insulin protocol. J Hosp Med. 2009;4:28–34.

  24. Devos PJ, Melot C. Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the Glucontrol study. Intensive Care Med. 2007;33(Suppl 2):S189-94.

  25. Dhar GC. Intensive glycemic control. Implications of the ACCORD, ADVANCE, and VADT trials for family physicians. Can Fam Physician. 2009;55(8):803–4.

  26. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes. N Engl J Med. 2009;360:129- 39.

  27. Duncan BC, Coughlin S, Li QE, Sherr D, Boren S. Assessing the value of diabetes education. Diabetes Educ. 2009;35:752–60.

  28. Duncan AE. Hyperglycemia and Perioperative Glucose Management. Curr Pharm Des. 2012;18(38):6195–203.

  29. Ezeani IU, Eregie A, Ogedengbe OS. Treatment outcome and prognostic indices in patients with hyperglycemic emergencies. Diabetes Metab Syndr Obes. 2013;6:303–7.

  30. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes. Diab Care. 1997;20:1183–97.

  31. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-97.

  32. Finney SJ, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003;290:2041-7.

  33. Freda BJ, Davidson MB, Hall PM. Evaluation of hyponatremia: a little physiology goes a long way. Cleve Clin J Med. August 2004; 71(8):639-50.

  34. Freudenthal TN, Podesta C, Mulholland R, Rossi M. Fluid Management in Diabetic Ketoacidosis. Are We Adhering to Recommended Guidelines? Br J Diabetes Vasc Dis. 2013; 13(3):138-42.

  35. Furnary AP. Effects of outcome on in-hospital transition from intravenous insulin infusion to subcutaneous therapy. Am J Cardiol. 2006;98:557–64.

  36. Gabbe SG, Garrison EA. New strategies for glucose control in patients with type 1 and type 2 diabetes mellitus in pregnancy. Clin Obstet Gynecol. 2007;50(4):1014-24.

  37. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, et al. American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary. Endocr Pract. 2013;32(6):536-57.

  38. Garber AJ, Bransome ED Jr. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2013;10:77-82.

  39. Genuth S, Bennett P. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diab Care. 2003;26:3160–7.

  40. Gerstein MM, Genuth S, ACCORD Study Group. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2011;364:818–28

  41. Giménez M, Nicolau J, Pericot A, Levy I. Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study. Acta Diabetol. 2007;44(1):34-7.

  42. Griesdale DE, de Souza RJ, van Dam RM. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180:821–7.

  43. Gross P. Treatment of Hyponatremia. Inter Med. 2008;47:885-91.

  44. Hoorn EJ, Tuut MK, Hoorntje SJ, van Saase LM, Zietse R, Geers AB. Dutch guideline for the management of electrolyte disorders – 2012 revision. The Netherlands Journal of Medicine. April 2013;71(3):153-65.

  45. Inzucchi SA. Management of Hyperglycemia in the Hospital Setting. N Engl J Med. 2006;355(18):1903-11.

  46. Inzucchi SA. Diagnosis of Diabetes. N Engl J Med. 2012;367:542-50.

  47. Inzucchi SE, Siegel D. Glucose Control in the ICU — How Tight Is Too Tight? N Engl J Med. 2009 March 2009;360(13):1346-8.

  48. Inzucchi SE. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diab Care. 2012;35:1364–79.

  49. Ismail-Beigi F, Banerji MA, ACCORD trial group. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010;376:419–30.

  50. Kavanagh BP. Glucose in the ICU — Evidence, Guidelines, and Outcomes. N Engl J Med. September 2012;367(13):1259-60.

  51. Kitabchi AE, Umpierrez GE, Fisher JN, Murphy MB, Stentz FB. Thirty Years of Personal Experience in Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State. J Clin Endocrinol Metab. May 2008;93(5):1541–52.

  52. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diab Care. 2009;32:1335–43.

  53. Kragelund Nielsen K, Kapur A. The urgent need for universally applicable simple screening procedures and diagnostic criteria for gestational diabetes mellitus – lessons from projects funded by the World Diabetes Foundation. Glob Health Action. 2012;5:1

  54. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med. 2007;35:2262–7.

  55. Lerario AC, Chacra AR, Pimazoni-Netto A, Malerbi D, Gross DJ, Oliveira JE, et al. Algorithm for the treatment of type 2 diabetes: a position statement of Brazilian Diabetes Society. Diabetology & Metabolic Syndrome. 2010(2):35.

  56. Hanefeld M, Bramlage P. Insulin Use Early in the Course of Type 2 Diabetes Mellitus: The ORIGIN Trial. Curr Diab Rep. 2013;13(3):342–9.

  57. Meier M. Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies. Vasc Health Risk Manag. 2009;5:859-71.

  58. Metchick LN, Inzucchi SE. Inpatient management of diabetes mellitus. Am J Med. 2002;113:317-23.

  59. Agus MS, Steil GM, Wypij D, Costello JM, Laussen PC, Langer M, et al. Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med 2012;367:1208-19.

  60. Kovalaske MA, Gandhi YG. Glycemic control in the medical intensive care unit. J Diabetes Sci Technol. 2009;3:1330-41.

  61. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diab Care. 2009;32:1119-31.

  62. Mooradian AD, Albert SG. Narrative review: a rational approach to starting insulin therapy. Ann Intern Med. 2006;145:125–34.

  63. Mugglestone MA. Management of diabetes from preconception to the postnatal period: summary of NICE guidance. BMJ. Mar 2008;336(7646):714–7.

  64. Nathan DM. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diab Care. 2009;32(193– 203):193.

  65. Nathan DM, International Expert Committee Members. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diab Care. Jul 2009;32(7):1327– 34.

  66. Olansky L, Lober C, Yared JP, Hoogwerf B. Cleveland Clinic Cardiovascular Intensive Care Unit Insulin Conversion Protocol. J Diabetes Sci Technol. May 2009;3(3):478–86.

  67. Perez ME, Rose C, Gaughan JP. Comparison of the Efficacy and Safety of Two Different Insulin Infusion Protocols in the Medical Intensive Care Unit. Hosp Pharm. 2013;48(3):213–8.

  68. Peters A. Diabetes care for emerging adults: recommendations for transition from pediatric to adult diabetes care systems: a position statement of the American Diabetes Association. Diab Care. Nov 2011;34(11):2477-85.

  69. Kalra P, Anakal M. Peripartum management of diabetes. Indian J Endocrinol Metab. 2013;17(suppl 1):S72–6.

  70. Pittas AG, Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med. 2004;164:2005-11.

  71. Reynolds RM, Padfield PL, Seckl JR. Disorders of sodium balance. BMJ. 2006;332:702-5.

  72. Robert G, Dluhy RG. Intensive Glycemic Control in the ACCORD and ADVANCE Trials. N Engl J Med. 2008(358):2630-3.

  73. Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grunberger G, et al. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract. 2009;15:540-59.

  74. Rozance PJ, Hay WW. Describing hypoglycemia - definition or operational threshold? Early Hum Dev. May 2010;86(5):275–80.

  75. Rury R, Holman FR. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes. N Engl J Med. October 2008;359:1577-89.

  76. Sacks DB, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2002;48:436–72.

  77. Saudek CD, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab. 2008;93:2447–53.

  78. Shomali MI, Hill PC, Pehlivanova M, Sharretts JM, Magee MF. Transition to target: a prospective randomized trial comparing three formulae for determination of subcutaneous basal insulin dosing at the time of transition from intravenous insulin therapy following cardiac surgery. Diabetes Technol Ther. 2011;13:121–6.

  79. Simmons D, McIntyre HD, Elrishi M. Gestational Diabetes Mellitus: NICE for the U.S.? A comparison of the American Diabetes Association and the American College of Obstetricians and Gynecologists guidelines with the U.K. National Institute for Health and Clinical Excellence guidelines. Diab Care. Jan 2010;33(1):34–7.

  80. Skyler JS, Bonow RO. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diab Care. Jan 2009;32:187–92.

  81. Stahnke A, Behnen E, Schimmelpfennig J. Pharmacy Management of Postoperative Blood Glucose in Open Heart Surgery Patients: Evaluation of an Intravenous to Subcutaneous Insulin Protocol. Hosp Pharm. Feb 2014;49(2):164–9.

  82. Tamborlane WV, Bode BW. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359:1464–76.

  83. The NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283-97.

  84. Tonelli MR, Guntupalli KK. An official multi-society statement: the role of clinical research results in the practice of critical care medicine. Am J Respir Crit Care Med. 2013;185:1117- 24.

  85. Turnbull FM, Anderson RJ. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia. 2009;52:2288-98

  86. Umpierrez GE, Smiley D, Mulligan P, Keyler T, Temponi A, Semakula C, et al. Insulin Analogs Versus Human Insulin in the Treatment of Patients With Diabetic Ketoacidosis. A randomized controlled trial. Diab Care. Jul 2009;32(7):1164–9.

  87. Umpierrez GE, Jacobs S. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diab Care. 2011;34:256–61.

  88. Umpierrez GE. Basal versus sliding-scale regular insulin in hospitalized patients with hyperglycemia during enteral nutrition therapy. Diab Care. 2009;32:751–3.

  89. Van den Berghe G, Wilmer A, Hermans G. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449–61.

  90. Van den Berghe G, Wouters P, Weekers F. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–67.

  91. Van Hooijdonk R, Winters T, Fischer J, van Dongen-Lases EC, Krinsley JS, Preiser JC. Accuracy and limitations of continuous glucose monitoring using spectroscopy in critically ill patients. Ann Intensive Care. 2014;4:1-8.

  92. Wiener RS, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a metaanalysis. JAMA. 2008;300:933–44.

  93. Zoungas S, Patel A, Chalmers J, de Galan BE, ADVANCE Collaborative Group. Severe Hypoglycemia and Risks of Vascular Events and Death. N Engl J Med. 2010;363:1410-8.




2020     |     www.medigraphic.com